Model JC200 Focused Ultrasound Tumor Therapeutic System

Non-invasive, extracorporeal ultrasound ablation treatment of tumors

Download the brochure of JC200

Indications

Solid tumors of all types of soft tissues such as:

Benign:

• Benign gynecologic tumors such as uterine fibroids

Malignant:

• liver tumors
• bone tumors
• breast tumors
• fibroadenoma of breast

Contraindications
•  Tumor of head 
•  Tumor in spine and vertebral canal 
•  Tumor of gastrointestinal tract
•  Tumor in thoracic cavity 
•  Tumor of hollow viscous with obstruction

Clinical Advangtages
• Noninvasive treatment to preserve organs and structures, with no blood transfusion and no radiation
• Conformal and precise ablation
• One time treatment, no limitation by tumor size and shape
• Real-time ultrasound-guided therapy with digital quantitative analysis
• Activation of immune system

Approvals: Europe: CE, China: CFDA

Package Price: three million and two hundred thousand US dollars ($3,200,000) to three million and nine hundred thousand US dollars ($3,900,000), including: 

1. The commodity of Model JC200 Focused Ultrasound Tumor Therapeutic System
2. HIFU doctor training
3. On-site clinical support
4. One (1) to five (5) years of guarantee and maintenance of the commodity
5. One (1) to five (5) years of clinical service via telemedicine center
6. One (1) to five (5) years of engineering service via telemedicine center
7. Five (5) years of software upgrade